LTBP2, latent transforming growth factor beta binding protein 2, 4053
N. diseases: 106; N. variants: 33
Source: ALL
Disease | Type | Disease Class | Semantic Type | N. genes d | N. SNPs d | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
group | Neoplasms | Neoplastic Process | 10161 | 1644 | 0.040 | None | 1.000 | 4 | 2011 | 2019 | |||||
|
group | Neoplasms | Neoplastic Process | 8621 | 1641 | 0.010 | None | 1.000 | 1 | 2017 | 2017 | |||||
|
group | Cardiovascular Diseases | Disease or Syndrome | 512 | 509 | 0.010 | None | 1.000 | 1 | 2020 | 2020 | |||||
|
group | Eye Diseases | Disease or Syndrome | 400 | 14 | 0.010 | None | < 0.001 | 1 | 2014 | 2014 | |||||
|
group | Cardiovascular Diseases | Disease or Syndrome | 537 | 45 | 0.010 | None | 1.000 | 1 | 2020 | 2020 | |||||
|
group | Digestive System Diseases | Disease or Syndrome | 656 | 42 | 0.010 | None | 1.000 | 1 | 2019 | 2019 | |||||
|
group | Neoplasms | Neoplastic Process | 569 | 154 | 0.010 | None | 1.000 | 1 | 2002 | 2002 | |||||
|
group | Neoplasms | Neoplastic Process | 371 | 7 | 0.010 | None | 1.000 | 1 | 2019 | 2019 | |||||
|
group | Neoplasms | Neoplastic Process | 8221 | 1374 | 0.010 | None | 1.000 | 1 | 2017 | 2017 | |||||
|
group | Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases | Congenital Abnormality | 426 | 87 | 0.100 | None | 0 | ||||||||
|
phenotype | Organism Attribute | 1903 | 3972 | 0.100 | None | 1.000 | 6 | 4 | 2010 | 2019 | |||||
|
phenotype | Diagnostic Procedure | 206 | 573 | 0.100 | None | 1.000 | 2 | 2 | 2018 | 2018 | |||||
|
phenotype | Pathological Conditions, Signs and Symptoms; Neoplasms | Neoplastic Process | 6243 | 355 | 0.020 | None | 1.000 | 2 | 2017 | 2019 | |||||
|
phenotype | Neoplastic Process | 6626 | 169 | 0.020 | None | 1.000 | 2 | 2017 | 2018 | ||||||
|
phenotype | Pathological Conditions, Signs and Symptoms; Respiratory Tract Diseases | Sign or Symptom | 222 | 26 | 0.010 | None | 1.000 | 1 | 2012 | 2012 | |||||
|
phenotype | Clinical Attribute | 430 | 746 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||
|
phenotype | Pathological Conditions, Signs and Symptoms | Neoplastic Process | 3865 | 72 | 0.010 | None | 1.000 | 1 | 2017 | 2017 | |||||
|
phenotype | Organism Attribute | 565 | 1138 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||
|
phenotype | Organism Attribute | 249 | 517 | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | |||||
|
phenotype | Clinical Attribute | 843 | 1931 | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||
|
phenotype | Neoplastic Process | 270 | 19 | 0.010 | None | 1.000 | 1 | 2019 | 2019 | ||||||
|
phenotype | Eye Diseases | Anatomical Abnormality | 7 | 0.010 | None | 1.000 | 1 | 2014 | 2014 | ||||||
|
phenotype | Eye Diseases | Finding | 113 | 5 | 0.100 | None | 0 | ||||||||
|
phenotype | Cardiovascular Diseases | Pathologic Function | 94 | 11 | 0.100 | None | 0 | ||||||||
|
phenotype | Pathological Conditions, Signs and Symptoms; Eye Diseases; Nervous System Diseases | Sign or Symptom | 227 | 7 | 0.100 | None | 0 |